EMA suggests restructuring eCTD to facilitate public access to documents
This article was originally published in SRA
Executive Summary
The European Medicines Agency wants drug regulatory authorities around the world to work towards restructuring the current eCTD (electronic common technical document) submission format to better enable redacting of commercially confidential information from these submissions so that they can be made available to the public1.